Potential of pH-sensitive polymer-anchored cationic liposomes for combinatorial anticancer therapy with doxorubicin and siRNA

U. H. Jeong, V. K. Garripelli, S. Jo, C. S. Myung, Sung Joo Hwang, J. K. Kim, J. S. Park

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

To explore a potential of pH-sensitive polymer-liposome complexes for the tumor-specific combinatorial delivery of anticancer agents and siRNA, conventional liposomes (ConL), polymer-liposome complexes (PLC) and polymer-cationic liposome complexes (PCLC) were prepared. Pluronic P104-based multiblock copolymer (MBCP-2) was included as pH-sensitive polymer. Physicochemical properties, release under different pH, cytotoxicity and in vitro cellular uptake of DOX-loaded liposomes were investigated. From the release test, an acidic pH was determined to be an important factor for release from the PLC vehicles. The novel PLC vehicle itself showed low cytotoxicity demonstrating suitable viability. Observing cellular uptake of DOX by confocal microscopy imaging, a greater amount of DOX was delivered to cells with the pH-sensitive polymer-anchored vehicles than that with free DOX and ConL. It was verified that the novel vehicles could effectively deliver both DOX and GFP-siRNA. Novel pH-sensitive PCLC have a potential for targeted therapy of anticancer agents and gene therapy under acidic tumor microenvironment.

Original languageEnglish
Pages (from-to)27-32
Number of pages6
JournalJournal of Drug Delivery Science and Technology
Volume24
Issue number1
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Liposomes
Doxorubicin
Small Interfering RNA
Polymers
Therapeutics
Antineoplastic Agents
Poloxamer
Tumor Microenvironment
Confocal Microscopy
Genetic Therapy

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Jeong, U. H. ; Garripelli, V. K. ; Jo, S. ; Myung, C. S. ; Hwang, Sung Joo ; Kim, J. K. ; Park, J. S. / Potential of pH-sensitive polymer-anchored cationic liposomes for combinatorial anticancer therapy with doxorubicin and siRNA. In: Journal of Drug Delivery Science and Technology. 2014 ; Vol. 24, No. 1. pp. 27-32.
@article{280eaca98c3a4d31998e560706011427,
title = "Potential of pH-sensitive polymer-anchored cationic liposomes for combinatorial anticancer therapy with doxorubicin and siRNA",
abstract = "To explore a potential of pH-sensitive polymer-liposome complexes for the tumor-specific combinatorial delivery of anticancer agents and siRNA, conventional liposomes (ConL), polymer-liposome complexes (PLC) and polymer-cationic liposome complexes (PCLC) were prepared. Pluronic P104-based multiblock copolymer (MBCP-2) was included as pH-sensitive polymer. Physicochemical properties, release under different pH, cytotoxicity and in vitro cellular uptake of DOX-loaded liposomes were investigated. From the release test, an acidic pH was determined to be an important factor for release from the PLC vehicles. The novel PLC vehicle itself showed low cytotoxicity demonstrating suitable viability. Observing cellular uptake of DOX by confocal microscopy imaging, a greater amount of DOX was delivered to cells with the pH-sensitive polymer-anchored vehicles than that with free DOX and ConL. It was verified that the novel vehicles could effectively deliver both DOX and GFP-siRNA. Novel pH-sensitive PCLC have a potential for targeted therapy of anticancer agents and gene therapy under acidic tumor microenvironment.",
author = "Jeong, {U. H.} and Garripelli, {V. K.} and S. Jo and Myung, {C. S.} and Hwang, {Sung Joo} and Kim, {J. K.} and Park, {J. S.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/S1773-2247(14)50004-4",
language = "English",
volume = "24",
pages = "27--32",
journal = "S.T.P. Pharma Sciences",
issn = "1773-2247",
publisher = "Editions de Sante",
number = "1",

}

Potential of pH-sensitive polymer-anchored cationic liposomes for combinatorial anticancer therapy with doxorubicin and siRNA. / Jeong, U. H.; Garripelli, V. K.; Jo, S.; Myung, C. S.; Hwang, Sung Joo; Kim, J. K.; Park, J. S.

In: Journal of Drug Delivery Science and Technology, Vol. 24, No. 1, 01.01.2014, p. 27-32.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Potential of pH-sensitive polymer-anchored cationic liposomes for combinatorial anticancer therapy with doxorubicin and siRNA

AU - Jeong, U. H.

AU - Garripelli, V. K.

AU - Jo, S.

AU - Myung, C. S.

AU - Hwang, Sung Joo

AU - Kim, J. K.

AU - Park, J. S.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - To explore a potential of pH-sensitive polymer-liposome complexes for the tumor-specific combinatorial delivery of anticancer agents and siRNA, conventional liposomes (ConL), polymer-liposome complexes (PLC) and polymer-cationic liposome complexes (PCLC) were prepared. Pluronic P104-based multiblock copolymer (MBCP-2) was included as pH-sensitive polymer. Physicochemical properties, release under different pH, cytotoxicity and in vitro cellular uptake of DOX-loaded liposomes were investigated. From the release test, an acidic pH was determined to be an important factor for release from the PLC vehicles. The novel PLC vehicle itself showed low cytotoxicity demonstrating suitable viability. Observing cellular uptake of DOX by confocal microscopy imaging, a greater amount of DOX was delivered to cells with the pH-sensitive polymer-anchored vehicles than that with free DOX and ConL. It was verified that the novel vehicles could effectively deliver both DOX and GFP-siRNA. Novel pH-sensitive PCLC have a potential for targeted therapy of anticancer agents and gene therapy under acidic tumor microenvironment.

AB - To explore a potential of pH-sensitive polymer-liposome complexes for the tumor-specific combinatorial delivery of anticancer agents and siRNA, conventional liposomes (ConL), polymer-liposome complexes (PLC) and polymer-cationic liposome complexes (PCLC) were prepared. Pluronic P104-based multiblock copolymer (MBCP-2) was included as pH-sensitive polymer. Physicochemical properties, release under different pH, cytotoxicity and in vitro cellular uptake of DOX-loaded liposomes were investigated. From the release test, an acidic pH was determined to be an important factor for release from the PLC vehicles. The novel PLC vehicle itself showed low cytotoxicity demonstrating suitable viability. Observing cellular uptake of DOX by confocal microscopy imaging, a greater amount of DOX was delivered to cells with the pH-sensitive polymer-anchored vehicles than that with free DOX and ConL. It was verified that the novel vehicles could effectively deliver both DOX and GFP-siRNA. Novel pH-sensitive PCLC have a potential for targeted therapy of anticancer agents and gene therapy under acidic tumor microenvironment.

UR - http://www.scopus.com/inward/record.url?scp=84894286326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894286326&partnerID=8YFLogxK

U2 - 10.1016/S1773-2247(14)50004-4

DO - 10.1016/S1773-2247(14)50004-4

M3 - Article

VL - 24

SP - 27

EP - 32

JO - S.T.P. Pharma Sciences

JF - S.T.P. Pharma Sciences

SN - 1773-2247

IS - 1

ER -